Among 358 community pharmacy leaders polled between July 25 and Aug. 5, 64 percent said brand name and generic versions of Adderall were on backorder, a survey from the National Community Pharmacists Association found.
In late July, Teva Pharmaceuticals told Blomberg it was experiencing “supply disruptions” of the drug. The company, which is the largest Adderall supplier in the U.S., said it expects supply levels to normalize in the next few weeks.
In 2021, the U.S. saw 41 million prescriptions for Adderall, marking a 10 percent increase from the year prior, according to data from Symphony Health cited by Bloomberg.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
